Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,238 | -18,581 | -72,781 | -55,348 | -35,963 |
| Depreciation Amortization | 509 | 255 | 1,071 | 812 | 556 |
| Accounts receivable | 98 | 55 | -274 | -15 | N/A |
| Accounts payable and accrued liabilities | -9 | -148 | 1,132 | 1,318 | 1,044 |
| Other Working Capital | 1,560 | 1,168 | -5,022 | -2,165 | -2,347 |
| Other Operating Activity | 7,776 | 2,656 | 21,752 | 16,031 | 10,382 |
| Operating Cash Flow | $-33,304 | $-14,595 | $-54,122 | $-39,367 | $-26,328 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -123 | -33 | -315 | -210 | -148 |
| Purchase Sale Intangibles | N/A | N/A | -20 | -20 | -20 |
| Other Investing Activity | 0 | 0 | -20 | -20 | -20 |
| Investing Cash Flow | $-123 | $-33 | $-335 | $-230 | $-168 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 54,312 | 2,269 | 17,154 | 16,773 | 14,807 |
| Other Financing Activity | 0 | -57 | 0 | 0 | 0 |
| Financing Cash Flow | $54,312 | $2,212 | $17,154 | $16,773 | $14,807 |
| Beginning Cash Position | 80,735 | 80,735 | 118,038 | 118,038 | 118,038 |
| End Cash Position | 101,620 | 68,319 | 80,735 | 95,214 | 106,349 |
| Net Cash Flow | $20,885 | $-12,416 | $-37,303 | $-22,824 | $-11,689 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,304 | -14,595 | -54,122 | -39,367 | -26,328 |
| Capital Expenditure | -123 | -33 | -315 | -210 | -148 |
| Free Cash Flow | -33,427 | -14,628 | -54,437 | -39,577 | -26,476 |